Literature DB >> 7782983

Attachment of Fusobacterium nucleatum to fibronectin immobilized on gingival epithelial cells or glass coverslips.

J P Babu1, J W Dean, M J Pabst.   

Abstract

To learn more about colonization of the oral epithelium by Fusobacterium nucleatum and the role of fibronectin in mediating adhesion of this microorganism, we studied attachment of this bacterium to cultured gingival epithelial cells that were coated with exogenous, purified plasma fibronectin. The three strains of F. nucleatum studied adhered in large numbers to epithelial cells that had been coated with fibronectin, compared with buffer-coated control cells. Bacterial adherence was also enhanced when epithelial cells were coated with whole human saliva. However, cells coated with saliva depleted of fibronectin did not facilitate adhesion of bacteria. Bacterial adhesion was restored when purified fibronectin was added back. We also tested adherence of bacteria to coverslips coated with fibronectin, saliva, and saliva depleted of fibronectin. The bacteria adhered to coverslips coated with fibronectin or whole human saliva, but did not adhere to coverslips coated with fibronectin-depleted saliva. Bacterial adhesion to coverslips was restored upon addition of purified fibronectin to the fibronectin-depleted saliva. Bacterial attachment to fibronectin-coated coverslips was found to be temperature-dependent, with maximal adhesion observed at 37 degrees C. Pre-treatment of F. nucleatum with soluble fibronectin inhibited attachment of the bacteria by 92%, whereas pre-treatment with bovine serum albumin had no effect. Pre-treatment of bacteria with laminin or type IV collagen caused moderate inhibition of attachment by 60% and 50%, respectively. Treatment of fibronectin-coated coverslips with Fab fragments of anti-fibronectin IgG blocked the attachment of F. nucleatum by 93%. Fab fragments of the other antisera tested had no inhibitory effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782983     DOI: 10.1902/jop.1995.66.4.285

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

Review 1.  Adhesion of anaerobic periodontal pathogens to extracellular matrix proteins.

Authors:  Andressa Temperine de Oliveira Marre; Regina M C P Domingues; Leandro A Lobo
Journal:  Braz J Microbiol       Date:  2020-06-17       Impact factor: 2.476

2.  Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells.

Authors:  Andrew M Edwards; Tracy J Grossman; Joel D Rudney
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells.

Authors:  Veli-Jukka Uitto; Daniel Baillie; Qiang Wu; Renee Gendron; Daniel Grenier; Edward E Putnins; Arja Kanervo; James D Firth
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Identification of a Fusobacterium nucleatum PK1594 galactose-binding adhesin which mediates coaggregation with periopathogenic bacteria and hemagglutination.

Authors:  B Shaniztki; D Hurwitz; N Smorodinsky; N Ganeshkumar; E I Weiss
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

5.  Identification and characterization of a novel adhesin unique to oral fusobacteria.

Authors:  Yiping W Han; Akihiko Ikegami; Chythanya Rajanna; Hameem I Kawsar; Yun Zhou; Mei Li; Hakimuddin T Sojar; Robert J Genco; Howard K Kuramitsu; Cheri X Deng
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

6.  Proteomics of Fusobacterium nucleatum within a model developing oral microbial community.

Authors:  Erik L Hendrickson; Tiansong Wang; David A C Beck; Brittany C Dickinson; Christopher J Wright; Richard J Lamont; Murray Hackett
Journal:  Microbiologyopen       Date:  2014-08-25       Impact factor: 3.139

7.  Fusobacterium nucleatum Subspecies Differ in Biofilm Forming Ability in vitro.

Authors:  Maria Muchova; Dario L Balacco; Melissa M Grant; Iain L C Chapple; Sarah A Kuehne; Josefine Hirschfeld
Journal:  Front Oral Health       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.